ABC | Volume 111, Nº1, July 2018

Special Article Ayub-Ferreira Guidelines for MCS of the BSC Arq Bras Cardiol. 2018; 111(1):4-12 Chart 8 – Complications of long-term mechanical circulatory support devices (MCSDs) Bleeding Pericardial effusion Respiratory insufficiency Right ventricular dysfunction Hypertension Non-neurological arterial thromboembolism Neurological events Arrhythmias Venous thromboembolism Infections Myocardial infarction Surgical wound dehiscence MCSD malfunction Hepatic dysfunction Psychiatric / behavioral change Hemolysis Renal dysfunction Chart 9 – Proposal of prioritization criteria for cardiac transplant Priority Criterium 1 Cardiogenic shock in patients using short/medium-term paracorporeal MCDS (including intra-aortic balloon) Long-term MCDS with complications and substitution of device is not possible 2 Cardiogenic shock in patients using inotropes or vasopressors 3 Stable long-term MCDS without complications 4 Outpatient management of advanced heart failure MCDS: mechanical circulatory device support 1. Kirklin JK, Naftel DC, Kormos RL, Stevenson LW, Pagani FD, Miller MA, et al. Third INTERMACS Annual Report: the evolution of destination therapy in the United States. J Heart Lung Transplant. 2011;30(2):115-23. 2. MoskowitzAJ,RoseEA,GelijnsAC.Thecostof long-termLVAD implantation. Ann Thorac Surg. 2001;71(3 Suppl):S195-8. 3. Rose EA, Gelijns AC, Moskowitz AJ, Heitjan DF, Stevenson LW, Dembitsky W, et al; Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) Study Group. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med. 2001;345(20):1435-43. 4. Reedy JE, Swartz MT, Termuhlen DF, Pennington DG, McBride LR, Miller LW, et al. Bridge to heart transplantation: importance of patient selection. J Heart Transplant. 1990;9(5):473-80. 5. Lietz K, Miller LW. Patient selection for left-ventricular assist devices. Curr Opin Cardiol. 2009;24(3):246-51. 6. Lietz K, Long JW, Kfoury AG, Slaughter MS, Silver MA, Milano CA, et al. Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection. Circulation. 2007;116(5):497-505. 7. Cowger J, Sundareswaran K, Rogers JG, Park SJ, Pagani FD, Bhat G, et al. Predicting survival in patients receiving continuous flow left ventricular assist devices: the HeartMate II risk score. J AmColl Cardiol. 2013;61(3):313-21. 8. Oz MC, Goldstein DJ, Pepino P, Weinberg AD, Thompson SM, Catanese KA, et al. Screening scale predicts patients successfully receiving long- term implantable left ventricular assist devices. Circulation. 1995;92(9 Suppl):II169-73. 9. Deng MC, Loebe M, El-Banayosy A, Gronda E, Jansen PG, Vigano M, et al. Mechanical circulatory support for advanced heart failure: effect of patient selection on outcome. Circulation. 2001;103(2):231-7. 10. SantamoreWP, Gray LA Jr. Left ventricular contributions to right ventricular systolic function during LVAD support. Ann Thorac Surg. 1996;61(1):350-6. 11. Loforte A, Stepanenko A, Potapov EV, Musumeci F, Dranishnikov N, Schweiger M, et al. Temporary right ventricular mechanical support in high- risk left ventricular assist device recipients versus permanent biventricular or total artificial heart support. Artif Organs. 2013;37(6):523-30. 12. Scalia GM, McCarthy PM, Savage RM, Smedira NG, Thomas JD. Clinical utility of echocardiography in the management of implantable ventricular assist devices. J Am Soc Echocardiogr. 2000;13(8):754-63. 13. Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2015;16(3):233-70. 14. Rudski LG, LaiWW, Afilalo J, Hua L, HandschumacherMD, Chandrasekaran K, et al. Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr. 2010;23(7):685-713. 15. Feldman D, Pamboukian SV, Teuteberg JJ, Birks E, Lietz K, Moore SA, et al; InternationalSocietyforHeartandLungTransplantation.The2013International SocietyforHeartandLungTransplantationGuidelinesformechanicalcirculatory support: executive summary. J Heart Lung Transplant. 2013;32(2):157-87. 16. Argiriou M, Kolokotron SM, Sakellaridis T, Argiriou O, Charitos C, Zarogoulidis P, et al. Right heart failure post left ventricular assist device implantation. J Thorac Dis. 2014 Mar;6 Suppl 1:S52-9. 17. MatthewsJC,KoellingTM,PaganiFD,AaronsonKD.Therightventricularfailure riskscoreapre-operativetoolforassessingtheriskofrightventricularfailureinleft ventricularassistdevicecandidates.JAmCollCardiol.2008;51(22):2163-72. 18. KormosRL,TeutebergJJ,PaganiFD,RussellSD,JohnR,MillerLW,etal;HeartMate II Clinical Investigators. Right ventricular failure in patients with theHeartMate II continuous-flowleftventricularassistdevice:incidence,riskfactors,andeffecton outcomes.JThoracCardiovascSurg.2010;139(5):1316-24. 19. Fitzpatrick JR 3 rd , Frederick JR, Hsu VM, Kozin ED, O’Hara ML, Howell E, et al. Risk score derived from pre-operative data analysis predicts the need for biventricular mechanical circulatory support. J Heart Lung Transplant. 2008;27(12):1286-92. References 11